Glycosyn LLC
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Feb 2032
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 17, 2027The maintenance fee for Microorganisms and methods for producing sialylated and N-acetylglucosamine-containing oligosaccharides (US 10,415,069) comes due Mar 17, 2027. Unpaid by Sep 17, 2027, it lapses early.
- 1 fee due May 26, 2027The maintenance fee for Biosynthesis of Human Milk Oligosaccharides in Engineered Bacteria (US 10,487,346) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.
Recent changes
- 1 term has ended since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,453,230 | Biosynthesis Of Human Milk Oligosaccharides In Engineered Bacteria In force · Medium confidence | In force | Medium confidence | |
| US 10,487,346 | Biosynthesis of Human Milk Oligosaccharides in Engineered Bacteria In force · Medium confidence | In force | Medium confidence | |
| US 10,815,511 | Biosynthesis Of Human Milk Oligosaccharides In Engineered Bacteria In force · High confidence | In force | High confidence | |
| US 10,286,001 | Use of purified 2′-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics In force · From the USPTO record | In force | From the USPTO record | |
| US 9,029,136 | Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides In force · From the USPTO record | In force | From the USPTO record | |
| US 9,587,241 | Biosynthesis of Human Milk Oligosaccharides in Engineered Bacteria In force · High confidence | In force | High confidence | |
| US 10,273,516 | Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides In force · From the USPTO record | In force | From the USPTO record | |
| US 10,415,069 | Microorganisms and methods for producing sialylated and N-acetylglucosamine-containing oligosaccharides In force · From the USPTO record | In force | From the USPTO record | |
| US 11,618,912 | Microorganisms and methods for producing sialylated and n-acetylglucosamine-containing oligosaccharides In force · From the USPTO record | In force | From the USPTO record | |
| US 11,643,675 | Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 10: 1 patent in force now held by others · 9 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
8 no status recorded